It is mainly engaged in the research, development, production and sales of pharmaceuticals, focusing on the development of characteristic APIs with barriers and complex preparations, and conducts the sales of APIs and preparations in domestic and international markets. It focuses on the development of characteristic APIs and complex preparations such as xanomeline tartrate, xanomeline, xanomeline intermediates, trospium chloride, methylene blue, etc....